Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptors

Neuropharmacology

Volumn 61, Issue 4, 2011, Pages 770-777

  Albizu, Laura ^a   Holloway, Terrell ^a   González Maeso, Javier ^a   Sealfon, Stuart C ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Antipsychotic; Crosstalk; Dopamine D2 receptor; Hallucinogen; Schizophrenia; Serotonin 5 HT2A receptor

Indexed keywords

DIZOCILPINE; DOPAMINE 2 RECEPTOR; INOSITOL PHOSPHATE; SEROTONIN 2A RECEPTOR;

ADULT ANIMAL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CELL STRAIN HEK293; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; LIGAND BINDING; LOCOMOTION; MALE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; SECOND MESSENGER;

ANIMALS; CELLS, CULTURED; DOPAMINE ANTAGONISTS; HEK293 CELLS; HUMANS; MALE; MICE; MICE, 129 STRAIN; MICE, KNOCKOUT; PROTEIN MULTIMERIZATION; RECEPTOR CROSS-TALK; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, DOPAMINE D2; SEROTONIN 5-HT2 RECEPTOR AGONISTS;

EID: 79959993845     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.05.023     Document Type: Article

References (50)

1. T. Adayev, B. Ranasinghe, and P. Banerjee Transmembrane signaling in the brain by serotonin, a key regulator of physiology and emotion Biosci. Rep. 25 2005 363 385 (Pubitemid 41712664)
2. L. Albizu, M.N. Balestre, C. Breton, J.P. Pin, M. Manning, and B. Mouillac Probing the existence of G protein-coupled receptor dimers by positive and negative ligand-dependent cooperative binding Mol. Pharmacol. 70 2006 1783 1791
3. L. Albizu, G. Teppaz, R. Seyer, H. Bazin, H. Ansanay, and M. Manning Toward efficient drug screening by homogeneous assays based on the development of new fluorescent vasopressin and oxytocin receptor ligands J. Med. Chem. 50 2007 4976 4985 (Pubitemid 47527131)
4. L. Albizu, M. Cottet, M. Kralikova, S. Stoev, R. Seyer, and I. Brabet Time-resolved FRET between GPCR ligands reveals oligomers in native tissues Nat. Chem. Biol. 6 2010 587 594
5. L. Albizu, J.L. Moreno, J. Gonzalez-Maeso, and S.C. Sealfon Heteromerization of G protein-coupled receptors: relevance to neurological disorders and neurotherapeutics CNS Neurol. Disord. Drug Targets 9 2010 636 650
6. O. Arias-Carrion, and E. Poppel Dopamine, learning, and reward-seeking behavior Acta Neurobiol. Exp. (Wars) 67 2007 481 488
7. D. Armstrong, and P.G. Strange Dopamine D2 receptor dimer formation: evidence from ligand binding J. Biol. Chem. 276 2001 22621 22629
8. L. Barki-Harrington, L.M. Luttrell, and H.A. Rockman Dual inhibition of beta-adrenergic and angiotensin II receptors by a single antagonist: a functional role for receptor-receptor interaction in vivo Circulation 108 2003 1611 1618 (Pubitemid 37187789)
9. D.O. Borroto-Escuela, W. Romero-Fernandez, A.O. Tarakanov, D. Marcellino, F. Ciruela, and L.F. Agnati Dopamine D2 and 5-hydroxytryptamine 5-HT(A) receptors assemble into functionally interacting heteromers Biochem. Biophys. Res. Commun. 401 2010 605 610
10. A. Bortolozzi, L. Diaz-Mataix, M.C. Scorza, P. Celada, and F. Artigas The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity J. Neurochem. 95 2005 1597 1607 (Pubitemid 41804057)
11. E.S. Bromberg-Martin, M. Matsumoto, and O. Hikosaka Dopamine in motivational control: rewarding, aversive, and alerting Neuron 68 2010 815 834
12. S. Bulenger, S. Marullo, and M. Bouvier Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation Trends Pharmacol. Sci. 26 2005 131 137 (Pubitemid 40313592)
13. P.J. Conn, and E. Sanders-Bush Selective 5HT-2 antagonists inhibit serotonin stimulated phosphatidylinositol metabolism in cerebral cortex Neuropharmacology 23 1984 993 996 (Pubitemid 14097227)
14. E. Costa The role of serotonin in neurobiology Int. Rev. Neurobiol. 2 1960 175 227
15. S. Damak, M. Rong, K. Yasumatsu, Z. Kokrashvili, V. Varadarajan, and S. Zou Detection of sweet and umami taste in the absence of taste receptor T1r3 Science 301 2003 850 853 (Pubitemid 36962629)
16. J. de Almeida, J.M. Palacios, and G. Mengod Distribution of 5-HT and DA receptors in primate prefrontal cortex: implications for pathophysiology and treatment Prog. Brain Res. 172 2008 101 115
17. M.D. Doherty, and V.M. Pickel Ultrastructural localization of the serotonin 2A receptor in dopaminergic neurons in the ventral tegmental area Brain Res. 864 2000 176 185 (Pubitemid 30235099)
18. T. Durroux Principles: a model for the allosteric interactions between ligand binding sites within a dimeric GPCR Trends Pharmacol. Sci. 26 2005 376 384 (Pubitemid 40848499)
19. S. Ferre, F. Ciruela, A.S. Woods, C. Lluis, and R. Franco Functional relevance of neurotransmitter receptor heteromers in the central nervous system Trends Neurosci. 30 2007 440 446 (Pubitemid 47381459)
20. W.F. Gattaz, B. Schummer, and S. Behrens Effects of zotepine, haloperidol and clozapine on MK-801-induced stereotypy and locomotion in rats J. Neural Transm. Gen. Sect. 96 1994 227 232
21. J. Giraldo On the fitting of binding data when receptor dimerization is suspected Br. J. Pharmacol. 155 2008 17 23
22. J. Gonzalez-Maeso, T. Yuen, B.J. Ebersole, E. Wurmbach, A. Lira, and M. Zhou Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex J. Neurosci. 23 2003 8836 8843 (Pubitemid 37210895)
23. J. Gonzalez-Maeso, N.V. Weisstaub, M. Zhou, P. Chan, L. Ivic, and R. Ang Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior Neuron 53 2007 439 452 (Pubitemid 46161267)
24. J. Gonzalez-Maeso, R.L. Ang, T. Yuen, P. Chan, N.V. Weisstaub, and J.F. Lopez-Gimenez Identification of a serotonin/glutamate receptor complex implicated in psychosis Nature 452 2008 93 97 (Pubitemid 351355090)
25. V.V. Gurevich, and E.V. Gurevich GPCR monomers and oligomers: it takes all kinds Trends Neurosci. 31 2008 74 81
26. N. Iqbal, and H.M. van Praag The role of serotonin in schizophrenia Eur. Neuropsychopharmacol. 1995 11 23 (Suppl. 5) (Pubitemid 26022214)
27. B.A. Jordan, and L.A. Devi G-protein-coupled receptor heterodimerization modulates receptor function Nature 399 1999 697 700 (Pubitemid 29289066)
28. J.N. Joyce The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine Psychopharmacology (Berl) 112 1993 S16 S34
29. S. Kapur, and G. Remington Serotonin-dopamine interaction and its relevance to schizophrenia Am. J. Psychiatry 153 1996 466 476 (Pubitemid 26113309)
30. T. Kienast, and A. Heinz Dopamine and the diseased brain CNS Neurol. Disord. Drug Targets 5 2006 109 131 (Pubitemid 43796630)
31. M. Laruelle, L.S. Kegeles, and A. Abi-Dargham Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment Ann. N. Y. Acad. Sci. 1003 2003 138 158 (Pubitemid 38083052)
32. S. Lukasiewicz, A. Polit, S. Kedracka-Krok, K. Wedzony, M. Mackowiak, and M. Dziedzicka-Wasylewska Hetero-dimerization of serotonin 5-HT(2A) and dopamine D(2) receptors Biochim. Biophys. Acta 1803 2010 1347 1358
33. J.J. Mann, D.A. Brent, and V. Arango The neurobiology and genetics of suicide and attempted suicide: a focus on the serotonergic system Neuropsychopharmacology 24 2001 467 477 (Pubitemid 32244308)
34. R. Mattera, B.J. Pitts, M.L. Entman, and L. Birnbaumer Guanine nucleotide regulation of a mammalian myocardial muscarinic receptor system. Evidence for homo- and heterotropic cooperativity in ligand binding analyzed by computer-assisted curve fitting J. Biol. Chem. 260 1985 7410 7421 (Pubitemid 15063016)
35. i values J. Pharmacol. Exp. Ther. 251 1989 238 246
36. G.G. Milligan Protein-coupled receptor hetero-dimerization: contribution to pharmacology and function Br. J. Pharmacol. 158 2009 5 14
37. J.P. Montmayeur, J. Guiramand, and E. Borrelli Preferential coupling between dopamine D2 receptors and G-proteins Mol. Endocrinol. 7 1993 161 170 (Pubitemid 23066858)
38. D.E. Nichols Hallucinogens Pharmacol. Ther. 101 2004 131 181 (Pubitemid 38167565)
39. D.E. Nichols, and C.D. Nichols Serotonin receptors Chem. Rev. 108 2008 1614 1641 (Pubitemid 351796401)
40. C. Nocjar, B.L. Roth, and E.A. Pehek Localization of 5-HT(2A) receptors on dopamine cells in subnuclei of the midbrain A10 cell group Neuroscience 111 2002 163 176 (Pubitemid 34310459)
41. A. Pazos, R. Cortes, and J.M. Palacios Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors Brain Res. 346 1985 231 249 (Pubitemid 16241112)
42. F.W. Reimherr, D.R. Wood, and P.H. Wender The use of MK-801, a novel sympathomimetic, in adults with attention deficit disorder, residual type Psychopharmacol. Bull. 22 1986 237 242 (Pubitemid 16101363)
43. M.L. Rives, C. Vol, Y. Fukazawa, N. Tinel, E. Trinquet, and M.A. Ayoub Crosstalk between GABAB and mGlu1a receptors reveals new insight into GPCR signal integration Embo J. 28 2009 2195 2208
44. R. Rozenfeld, and L.A. Devi Receptor heteromerization and drug discovery Trends Pharmacol. Sci. 31 2010 124 130
45. J.Y. Springael, P.N. Le Minh, E. Urizar, S. Costagliola, G. Vassart, and M. Parmentier Allosteric modulation of binding properties between units of chemokine receptor homo- and hetero-oligomers Mol. Pharmacol. 69 2006 1652 1661
46. S. Terrillon, and M. Bouvier Roles of G-protein-coupled receptor dimerization Embo Rep. 5 2004 30 34 (Pubitemid 38228524)
47. E. Urizar, L. Montanelli, T. Loy, M. Bonomi, S. Swillens, and C. Gales Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity Embo J. 24 2005 1954 1964 (Pubitemid 40896167)
48. M.L. Wong, and J. Licinio Research and treatment approaches to depression Nat. Rev. Neurosci. 2 2001 343 351 (Pubitemid 33680576)
49. K.A. Wreggett, and J.W. Wells Cooperativity manifest in the binding properties of purified cardiac muscarinic receptors J. Biol. Chem. 270 1995 22488 22499
50. G.Q. Zhao, Y. Zhang, M.A. Hoon, J. Chandrashekar, I. Erlenbach, and N.J. Ryba The receptors for mammalian sweet and umami taste Cell 115 2003 255 266 (Pubitemid 37487700)